Avita Medical | Attività Correnti



Current Assets Cambiamento Data
Adcock Ingram Holdings ZAR 5.12B 234.71M 2024-12
Celltrion KRW 5.46T 122.95B 2025-03
Clinuvel Pharmaceuticals AUD 222.06M 20.56M 2024-06
Cochlear AUD 1.41B 41.5M 2024-12
CSL USD 11.31B 540M 2024-12
Cspc Pharmaceutical CNY 21.89B 4.58B 2024-12
Dianthus Therapeutics USD 263.6M 17.3M 2025-06
Divis Laboratories Ltd 100.81B 7.4B 2025-03
Kangmei Pharma CNY 6.9B 6.92M 2025-06
Knight Therapeutics CAD 397.57M 36.96M 2024-09
Laboratorios Farma EUR 516.3M 26.69M 2025-06
Malin Corporation EUR 62.6M 26.7M 2024-12
Mayne Pharma AUD 460.59M 14.71M 2024-06
Medical Developments International AUD 33.41M 7.26M 2024-12
Nanosonics AUD 210.09M 11.64M 2024-12
Neuren Pharmaceuticals AUD 399.33M 171.29M 2024-12
Organigram Holdings CAD 277.78M 46.29M 2025-06
Pacific Edge NZD 30.82M 13.49M 2025-03
Paradigm Biopharmaceuticals AUD 32.29M 8.04M 2024-12
Pharma Mar EUR 249.4M 13.39M 2025-06
Polynovo AUD 79.3M 9.02M 2024-06
PYC Therapeutics AUD 62.12M 23.49M 2024-12
Qiagen NV USD 1.82B 76.12M 2025-06
Ramsay Health Care AUD 3.41B 465.3M 2024-12
ResMed USD 3.51B 669.42M 2025-06
Sartorius EUR 2.17B 7.5M 2025-06
Sino Biopharmaceutical CNY 24.69B 536.66M 2024-12
Telix Pharmaceuticals AUD 918.56M 663.3M 2024-12
Tilray USD 707.34M 18.54M 2024-11
Zz Pientze Pharmaceu 12.29B 113.34M 2025-06


Avita Medical Attività Correnti - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Sep 2025.